Node Status Pending Review Learning Objectives Discuss Hematological Abnormalities as an ADR to DR-TB Treatment, suspected agent. Enumerate suggested management strategies for Hematological Abnormalities. Linked Nodes Management of DR-TB ADR KM Node Tags DR-TB and PMDT Linked Content Page ID Page title Content Status Content Creator LMS Page Link Language Reviewer 1003 Management of DR-TB ADR: Hematological Abnormalities Page Prioritised Archana.Singh LMSLink English Abhimanyu